… rx 150 mg or 300 mg once daily vs placebo 12 months Safety … medications were randomized
to isradipine or placebo for a … a multicenter study of sustained-release exenatide in early PD …

… To date, comparative trials of antihypertensive agents in … Once daily dosing with enalapril
or lisinopril lowers trough … formulation, sustained release nifedipine and isradipine appears to …

… -availability and sustained release of drugs and protects drugs from enzymatic degradation.
… size could increase the dissolution rate of isradipine by providing a stable nanosuspension. …

… antianginal medications reduced the number of angina episodes per week, delayed time to
ST-segment depression, and had comparable efficacy to conventional antianginal therapies. …

… more antihypertensive drugs … hypertension (night-time SBP≥120/70 mmHg) 90 . In our
study, we changed the time of administration of all of the individual’s once-daily antihypertensive …

… domain plus other detailed evaluation items, the aim of the current pilot study was to
investigate the effects of discontinuing antihypertensive drugs on frailty syndrome in outpatients. …

… in comparison with other antihypertensive agents 39 ; however inclusion of observational
studies in this analysis … , and that long-acting drugs in once daily formulations should be used. …

… of delivery from a sustained release preparation. The fraction … to provide more comparable
control of efficacy regardless of … then 20 mg once daily and 150 mg once daily to prevent the …

… as an affordable, single, once-daily combination pill. If blood … Global, regional, and national
comparative risk assessment … , 1990-2017: A systematic analysis for the Global Burden of …

… monotherapy in the treatment of mild systolic hypertension whenever possible. The ideal
choice is a drug that is effective for 24 hours when given once daily and that produces few or no …